Protein kinase GSK3β regulates tumor suppressor pdcd4 expression in lung cancer cells

An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β

(2012) Katsuyoshi Miyashita et al.   Anti-Cancer Agents in Medicinal Chemistry

Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation

(2011) Tobias Schmid et al.   CARCINOGENESIS

MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand

(2010) Danish Sayed et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

WNT Signaling in Lung Disease

(2009) Melanie Königshoff et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion

(2008) T. Schmid et al.   CANCER RESEARCH

Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors

(2008) Svetlana V. Kalinichenko et al.   LUNG CANCER